Adil Daud is an expert in the therapy and development of drugs for melanoma. His fellowship in medical oncology was at the Memorial Sloan Kettering Cancer Center and was a faculty member at the Moffitt Cancer Center in Tampa, Fl. He is currently Professor of Medicine and Dermatology at the University of California, San Francisco. He is the director of the Melanoma Program at the Helen Diller Family Cancer Center. Over the last decade, he has been involved in several key clinical trials, focusing on novel targeted therapy and immunotherapy for melanoma and for other tumors. His recent research has focused on the microenvironment as it related to the immune system.